2004
DOI: 10.1016/j.ijantimicag.2004.08.006
|View full text |Cite
|
Sign up to set email alerts
|

Community-acquired pneumonia: new management strategies for evolving pathogens and antimicrobial susceptibilities

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

2
4
0

Year Published

2005
2005
2016
2016

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 16 publications
(6 citation statements)
references
References 99 publications
2
4
0
Order By: Relevance
“…Continuous monitoring offers the additional advantage of revealing sudden and dangerous changes in resistance trends, an occurrence of remarkable medical significance. In fact, decreased susceptibility to certain classes of drugs, as observed in vitro, may lead to lack of eradication of the causative pathogen thus generating clinical failures and recurrences [11][12][13][14][15][16]. The present Sentinel Project extends previous findings that emerged during longitudinal studies performed in Italy during the 1990s [2,3].…”
Section: Discussionsupporting
confidence: 58%
“…Continuous monitoring offers the additional advantage of revealing sudden and dangerous changes in resistance trends, an occurrence of remarkable medical significance. In fact, decreased susceptibility to certain classes of drugs, as observed in vitro, may lead to lack of eradication of the causative pathogen thus generating clinical failures and recurrences [11][12][13][14][15][16]. The present Sentinel Project extends previous findings that emerged during longitudinal studies performed in Italy during the 1990s [2,3].…”
Section: Discussionsupporting
confidence: 58%
“…In this study, we found that 72.6% and 83.3% of all strains were not susceptible to penicillin and macrolides, respectively, numbers that were very close to the findings of previous studies (14,30). One possible cause of the increase in drug resistance is long-term antimicrobial therapy (15). To date it has been thought that the priority for clinicians is to choose the appropriate chemotherapy for patients, usually with underlying diseases.…”
Section: Discussionsupporting
confidence: 88%
“…Due to the severity of these infections and the difficulties in determining the bacterial etiology and the antimicrobial susceptibility, treatment is often empirical, consisting usually of orally administered agents. The choice of empiric antimicrobial chemotherapy is guided by the clinical presentation, the severity of the infection, and epidemiologic data, comprising the causative organisms and their susceptibility to antimicrobial agents [2, 3]. …”
Section: Introductionmentioning
confidence: 99%